Stock Analysts’ Updated EPS Estimates for September, 8th (ABBV, ABLYF, ADAP, BFNC, BYPLF, CAB, CHRS, CLIGF, CLPBY, CLR)

Stock Analysts’ updated eps estimates for Friday, September 8th:

AbbVie (NYSE:ABBV) had its buy rating reissued by analysts at Jefferies Group LLC. They currently have a $94.00 price target on the stock.

Ablynx N.V. (NASDAQ:ABLYF) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Ablynx NV is a biopharmaceutical company which engaged in the development of Nanobodies (R) proprietary therapeutic proteins based on single-domain antibody fragments. The company also discovers and develops therapeutic for inflammation, haematology, immuno-oncology, oncology and respiratory disease. Ablynx NV is headquartered in Ghent, Belgium. “

Adaptimmune Therapeutics PLC (NASDAQ:ADAP) had its outperform rating reaffirmed by analysts at Leerink Swann. They currently have a $15.00 price target on the stock.

Hovde Group assumed coverage on shares of Bank First National Corp (OTC:BFNC). Hovde Group issued an outperform rating and a $44.00 price target on the stock.

Bodycote Plc (NASDAQ:BYPLF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bodycote PLC provides thermal processing services through heat treatment, metal joining, surface technology and Hot Isostatic Pressing. It serves aerospace, defense, automotive, power generation, oil & gas, construction, medical and transportation industry. Bodycote PLC is headquartered in Macclesfield, the United Kingdom. “

Cabela’s (NYSE:CAB) had its hold rating reaffirmed by analysts at Stifel Nicolaus. The firm currently has a $61.50 target price on the stock, up from their previous target price of $59.00.

Coherus BioSciences (NASDAQ:CHRS) had its outperform rating reissued by analysts at Cowen and Company. The firm currently has a $45.00 price target on the stock.

Clinigen Group Plc (NASDAQ:CLIGF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Clinigen Group plc is a pharmaceutical and services company. Its business focuses in areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen Group plc is headquartered in Burton-on-Trent, the United Kingdom. “

Coloplast A/S (NASDAQ:CLPBY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Coloplast A/S develops and provides health care products and services. Its operating business segments consist of Chronic Care, Urology Care and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Urology Care segment offers urological products, including disposable products. The Wound and Skin Care segment covers the sale of wound and skin care products. Coloplast A/S is headquartered in Humlebaek, Denmark. “

Continental Resources (NYSE:CLR) had its target price trimmed by Scotiabank from $14.00 to $13.50. The firm currently has an outperform rating on the stock.

Coupa Software (NASDAQ:COUP) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Coupa Software Inc. provides cloud-based spend management platform which connects organizations with suppliers. Coupa Software Inc. is based in SAN MATEO, United States. “

Camping World Holdings (NYSE:CWH) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Camping World Holdings, Inc. is a provider of services, protection plans, products and resources for recreational vehicle enthusiasts. The company’s brand consists of Camping World and Good Sam. It offers new and used RVs for sale, vehicle service and maintenance through retail locations and membership clubs. Camping World Holdings, Inc. is based in Lincolnshire, United States. “

DBV Technologies (NASDAQ:DBVT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “DBV Technologies SA is a biopharmaceutical company. It develops products and immunotherapies for the diagnosis and treatment of various food allergies, including milk and peanut. The Company delivers biological immunoactive compounds, such as allergens, to the immune system by targeting the antigen-presenting cells present in skin. DBV Technologies SA is headquartered in Bagneux, France. “

Dominion Diamond Corp (TSE:DDC) (NYSE:DDC) was downgraded by analysts at Scotiabank from an outperform rating to a sector perform rating. Scotiabank currently has C$17.50 price target on the stock.

Descartes Systems Group (TSE:DSG) (NASDAQ:DSGX) had its price target raised by Raymond James Financial, Inc. to C$38.00. They currently have an outperform rating on the stock.

Dometic Group Ab (NASDAQ:DTCGF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Dometic Group AB provides branded solutions for mobile living in the areas of Climate, Hygiene & Sanitation and Food & Beverage. It offers products for use in recreational vehicles, trucks and premium cars, pleasure and workboats and for a variety of other uses. The company operates primarily in the Americas, EMEA and Asia Pacific. Dometic Group AB is headquartered in Solna, Sweden. “

DexCom (NASDAQ:DXCM) had its overweight rating reissued by analysts at Piper Jaffray Companies. Piper Jaffray Companies currently has a $87.00 price target on the stock.

Franco Nevada Corp (TSE:FNV) (NYSE:FNV) had its target price boosted by Scotiabank to C$100.00. They currently have a sector perform rating on the stock.

General Motors (NYSE:GM) (TSE:GMM.U) had its neutral rating reissued by analysts at Buckingham Research. They currently have a $33.00 price target on the stock.

Hewlett Packard Enterprise (NYSE:HPE) had its hold rating reiterated by analysts at Loop Capital. Loop Capital currently has a $14.50 target price on the stock, down from their previous target price of $17.00.

Hanwha Q CELLS Co. (NASDAQ:HQCL) had its sell rating reaffirmed by analysts at Axiom Securities.

IAMGOLD Corp (TSE:IMG) (NYSE:IAG) had its target price increased by Raymond James Financial, Inc. to C$9.00. They currently have a market perform rating on the stock.

Independence Realty Trust (NYSE:IRT) had its buy rating reissued by analysts at Ladenburg Thalmann Financial Services. Ladenburg Thalmann Financial Services currently has a $11.00 price target on the stock.

Intra-Cellular Therapies (NASDAQ:ITCI) had its hold rating reiterated by analysts at SunTrust Banks, Inc.. They currently have a $22.00 target price on the stock, up from their previous target price of $16.00.

JA Solar Holdings, Co. (NASDAQ:JASO) had its sell rating reiterated by analysts at Axiom Securities.

Malibu Boats (NASDAQ:MBUU) had its buy rating reiterated by analysts at SunTrust Banks, Inc.. They currently have a $32.00 price target on the stock, up from their previous price target of $30.00.

Restoration Hardware Holdings (NYSE:RH) had its hold rating reaffirmed by analysts at Loop Capital. Loop Capital currently has a $55.00 target price on the stock.

SSR Mining (TSE:SSRM) had its outperform rating reissued by analysts at BMO Capital Markets. The firm currently has a C$14.00 price target on the stock.

T-Mobile US (NASDAQ:TMUS) had its hold rating reiterated by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $70.00 target price on the stock.

TherapeuticsMD (NASDAQ:TXMD) had its buy rating reissued by analysts at Jefferies Group LLC. Jefferies Group LLC currently has a $15.00 target price on the stock.

United States Steel Corporation (NYSE:X) had its market perform rating reiterated by analysts at BMO Capital Markets.

Yingli Green Energy Holding Company Limited (NYSE:YGE) had its sell rating reissued by analysts at Axiom Securities.